Growth Metrics

Pulmonx (LUNG) Debt to Equity (2019 - 2025)

Pulmonx (LUNG) reported Debt to Equity of $0.69 for Q4 2025, up 58.21% year-over-year from $0.43 in Q4 2024, and up 10.83% on a QoQ basis from $0.62 in Q3 2025.

Pulmonx (LUNG) has 7 years of Debt to Equity data on file, last reported at $0.69 in Q4 2025.

  • Quarterly Debt to Equity rose 58.21% year-over-year to $0.69 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $0.69 (up 58.21% YoY) and the FY2025 annual result came in at $0.69, up 58.21% from the prior year.
  • Debt to Equity improved to $0.69 in Q4 2025 per LUNG's latest filing, from $0.62 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.69 in Q4 2025 and bottomed at $0.0 in Q4 2021.
  • The 5-year median for Debt to Equity is $0.29 (2023), against an average of $0.27.
  • The widest annual swing landed in 2021, when Debt to Equity slumped 43.98%; it then surged 7950.79% in 2022.
  • Tracing LUNG's Debt to Equity over 5 years: stood at $0.0 in 2021, then surged by 7950.79% to $0.11 in 2022, then soared by 179.84% to $0.31 in 2023, then surged by 37.64% to $0.43 in 2024, then surged by 58.21% to $0.69 in 2025.
  • Per Business Quant, the three latest LUNG Debt to Equity figures stand at $0.69 (Q4 2025), $0.62 (Q3 2025), and $0.54 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.65
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.64
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.57
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.95
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.27
10 Pulmonx 67.30 Mn -2.45 Mn - 0.69

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.69
Sep 30, 2025 0.62
Jun 30, 2025 0.54
Mar 31, 2025 0.48
Dec 31, 2024 0.43
Sep 30, 2024 0.40
Jun 30, 2024 0.37
Mar 31, 2024 0.34
Dec 31, 2023 0.31
Sep 30, 2023 0.30
Jun 30, 2023 0.28
Mar 31, 2023 0.26
Dec 31, 2022 0.11
Sep 30, 2022 0.11
Jun 30, 2022 0.10
Mar 31, 2022 0.10
Dec 31, 2021 0.00
Sep 30, 2021 0.02
Jun 30, 2021 0.01
Mar 31, 2021 0.00
Dec 31, 2020 0.00
Sep 30, 2020 -0.01
Dec 31, 2019 -0.01